DiaSorin (OTCMKTS:DSRLF) Stock Price Down 5% – Here’s Why

DiaSorin S.p.A. (OTCMKTS:DSRLF) shares were down 5% during mid-day trading on Tuesday . The company traded as low as $79.05 and last traded at $79.05. Approximately 100 shares traded hands during mid-day trading, The stock had previously closed at $83.17.

Wall Street Analyst Weigh In

A number of equities analysts have commented on DSRLF shares. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating on shares of DiaSorin in a research note on Tuesday, February 10th. BNP Paribas Exane raised shares of DiaSorin to a “neutral” rating in a research report on Wednesday, January 28th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, DiaSorin presently has a consensus rating of “Moderate Buy”.

DiaSorin Stock Performance

The business’s 50-day simple moving average is $79.23 and its two-hundred day simple moving average is $86.60.

About DiaSorin

DiaSorin S.p.A. is an Italy‐based global biotechnology company specializing in the development, manufacture and marketing of in vitro diagnostic products. Headquartered in Saluggia, DiaSorin serves clinical laboratories, hospitals and physician offices with a broad portfolio of immunodiagnostic assays and molecular diagnostic tests. The company’s shares trade on the Milan Stock Exchange and are available in the United States as over‐the‐counter (OTC) securities under the symbol DSRLF.

At the core of DiaSorin’s business are immunodiagnostic systems that measure antibodies, antigens and hormones in human samples.